Chun-Yu Lee, MD
Cardiovascular Disease (Cardiology) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 8
Offices
8 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lee’s office to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$200,932
Medicare paid this office $200,932 for 1,049 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 275 | $33,868 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 148 | $27,465 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $12,755 | $100 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 56 | $11,707 | $205 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $11,349 | $378 |
See all 34 services
| Return visit (30+ min) | 275 | $33,868 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 148 | $27,465 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $12,755 | $100 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 56 | $11,707 | $205 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $11,349 | $378 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 35 | $10,894 | $303 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $10,258 | $144 |
| Critical care, first 30-74 minutes | 21 | $9,598 | $185 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 139 | $7,577 | $55 |
| New patient visit (45+ min) | 45 | $5,683 | $126 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 340 | $5,005 | $12 |
| Long return visit (40+ min) | 37 | $4,673 | $123 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 20 | $4,135 | $197 |
| New patient visit (60+ min) | 22 | $3,801 | $173 |
| Hospital discharge day management, more than 30 minutes | 38 | $3,779 | $99 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 32 | $2,810 | $78 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 241 | $2,693 | $7 |
| Insertion of tube in right heart chambers for measurement | 20 | $2,018 | $101 |
| Short return visit (20+ min) | 21 | $1,916 | $77 |
| New patient visit (30+ min) | 21 | $1,812 | $86 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,310 | $94 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 110 | $1,210 | $10 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 20 | $1,193 | $60 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 47 | $972 | $21 |
| 3d radiographic procedure | 37 | $948 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $507 | $24 |
| Ultrasound of heart, follow-up | 21 | $484 | $20 |
| Heart muscle strain imaging | 12 | $464 | $39 |
| Heart rhythm recording of continous external ekg over 8-15 days | 36 | $404 | $11 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $288 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $252 | $16 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $225 | $20 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $87 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $82 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 37 | More than 72% of doctors who do this |
Who their Medicare patients are
1,049 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 17% · Women 49% · Also on Medicaid 41% · Health risk score 2.04. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · Atrial fibrillation 42% · Diabetes 39% · Chronic kidney disease 39% · Heart failure 38% · Depression 20% · Cancer 19% · COPD 17% · Stroke 14% · Dementia 12%.
The office billed $1,114,293, Medicare allowed $278,347 and paid $200,932; for 2,625 services of 67 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,049 | 2,625 | 75 | 2.04 | $1,114,293 | $200,932 |
| 2023 | 1,068 | 2,617 | 75 | 1.89 | $1,032,575 | $202,233 |
| 2022 | 1,159 | 2,997 | 75 | 1.97 | $1,130,653 | $225,528 |
| 2021 | 1,065 | 2,844 | 75 | 2.14 | $1,033,308 | $220,335 |
| 2020 | 1,127 | 2,695 | 74 | 2.31 | $924,669 | $183,307 |
| 2019 | 514 | 945 | 75 | 2.22 | $227,998 | $48,117 |
| 2018 | 52 | 88 | 76 | 3.40 | $27,874 | $6,990 |
| 2017 | 30 | 56 | 77 | 1.78 | $17,061 | $4,459 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 31 services
| Return visit (30+ min) | 252 | $32,499 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 137 | $26,351 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $15,975 | $108 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 56 | $12,151 | $217 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $11,592 | $157 |
| Critical care, first 30-74 minutes | 23 | $10,610 | $189 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 177 | $10,465 | $57 |
| New patient visit (45+ min) | 56 | $8,310 | $148 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 26 | $8,153 | $302 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $8,139 | $407 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 28 | $5,943 | $212 |
| Long return visit (40+ min) | 28 | $4,962 | $160 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 300 | $4,341 | $12 |
| Hospital discharge day management, more than 30 minutes | 36 | $3,686 | $102 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 303 | $3,533 | $7 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 33 | $2,802 | $80 |
| Short return visit (20+ min) | 33 | $2,354 | $67 |
| Insertion of tube in right heart chambers for measurement | 19 | $2,183 | $109 |
| External shock to heart to regulate heart beat | 16 | $1,653 | $92 |
| Ultrasound of heart blood flow, valves and chambers | 28 | $1,481 | $53 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 102 | $1,124 | $11 |
| 3d radiographic procedure | 45 | $1,116 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | $717 | $26 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $678 | $62 |
| Heart muscle strain imaging | 14 | $547 | $39 |
| Ultrasound of heart, follow-up | 17 | $406 | $23 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 17 | $400 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $194 | $15 |
| Heart rhythm recording of continous external ekg over 8-15 days | 16 | $185 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $127 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $56 | $3 |
2022: 32 services
| Return visit (30+ min) | 248 | $36,955 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 146 | $28,501 | $186 |
| Critical care, first 30-74 minutes | 26 | $15,731 | $190 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 30 | $15,031 | $455 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $13,121 | $88 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 40 | $12,391 | $310 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 59 | $11,936 | $202 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 166 | $10,066 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $10,041 | $165 |
| New patient visit (45+ min) | 80 | $8,973 | $112 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 39 | $8,912 | $229 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 396 | $4,567 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 300 | $4,280 | $11 |
| Short return visit (20+ min) | 49 | $3,717 | $68 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 36 | $2,931 | $81 |
| Long return visit (40+ min) | 14 | $2,551 | $159 |
| Hospital discharge day management, more than 30 minutes | 25 | $2,409 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,109 | $62 |
| Ultrasound of heart blood flow, valves and chambers | 37 | $1,968 | $53 |
| Insertion of tube in right heart chambers for measurement | 17 | $1,804 | $106 |
| 3d radiographic procedure | 62 | $1,467 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 119 | $1,407 | $11 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 20 | $1,220 | $61 |
| External shock to heart to regulate heart beat | 12 | $1,188 | $99 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 38 | $974 | $26 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 13 | $744 | $57 |
| Heart muscle strain imaging | 16 | $669 | $39 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 23 | $562 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $335 | $15 |
| Heart rhythm recording of continous external ekg over 8-15 days | 21 | $286 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $156 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $58 | $3 |
2021: 31 services
| Return visit (30+ min) | 194 | $34,024 | $103 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 97 | $19,921 | $203 |
| Critical care, first 30-74 minutes | 41 | $17,669 | $194 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 53 | $16,639 | $314 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 93 | $16,176 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $15,103 | $92 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $14,044 | $453 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 162 | $9,737 | $60 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 42 | $9,242 | $220 |
| Long return visit (40+ min) | 45 | $8,687 | $158 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 23 | $5,222 | $227 |
| New patient visit (45+ min) | 43 | $5,208 | $121 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 414 | $4,726 | $8 |
| Short return visit (20+ min) | 63 | $4,410 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 239 | $3,842 | $12 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 38 | $3,310 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,793 | $61 |
| Hospital discharge day management, more than 30 minutes | 28 | $2,736 | $98 |
| Insertion of tube in right heart chambers for measurement | 19 | $2,078 | $109 |
| External shock to heart to regulate heart beat | 12 | $1,409 | $101 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 116 | $1,360 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 24 | $1,328 | $55 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,087 | $91 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 17 | $1,056 | $62 |
| Hospital discharge day management, 30 minutes or less | 17 | $995 | $59 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 28 | $696 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $645 | $27 |
| 3d radiographic procedure | 26 | $594 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $348 | $16 |
| Heart rhythm recording of continous external ekg over 8-15 days | 22 | $313 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $60 | $3 |
2020: 34 services
| Return visit (30+ min) | 133 | $19,363 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 90 | $18,424 | $198 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $15,901 | $179 |
| Critical care, first 30-74 minutes | 31 | $14,838 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $13,951 | $92 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 18 | $10,116 | $460 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 140 | $9,198 | $64 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $7,055 | $214 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 23 | $7,051 | $307 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 566 | $6,235 | $7 |
| Short return visit (20+ min) | 78 | $6,155 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $3,713 | $64 |
| Long return visit (40+ min) | 26 | $3,709 | $137 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,400 | $262 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 169 | $3,051 | $15 |
| New patient visit (45+ min) | 26 | $2,912 | $112 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $2,716 | $209 |
| Insertion of tube in right heart chambers for measurement | 22 | $2,494 | $108 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $2,276 | $163 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 25 | $2,215 | $82 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,679 | $99 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,453 | $66 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,358 | $91 |
| External shock to heart to regulate heart beat | 12 | $1,214 | $93 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 100 | $1,210 | $11 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 17 | $1,080 | $64 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 30 | $669 | $22 |
| External ekg recording for more than 48 hours up to 21 days | 27 | $652 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $366 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $337 | $26 |
| Ultrasound of heart, follow-up | 13 | $325 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $262 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $219 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $64 | $3 |
2019: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $5,979 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,190 | $179 |
| Critical care, first 30-74 minutes | 12 | $4,834 | $193 |
| Return visit (30+ min) | 35 | $3,709 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 54 | $3,380 | $63 |
| Short return visit (20+ min) | 47 | $3,173 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 269 | $2,997 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 14 | $2,888 | $206 |
| New patient visit (45+ min) | 13 | $1,642 | $126 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 82 | $1,324 | $16 |
| New patient visit (30+ min) | 12 | $993 | $83 |
| Hospital discharge day management, 30 minutes or less | 11 | $724 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $200 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $173 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $165 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $29 | $3 |
2018: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $4,859 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,372 | $60 |
2017: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,612 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,551 | $65 |
Medicaid work
$23,464 in 2024
Medicaid paid $23,464 for 758 billed services this clinician did in 2024, up to 47 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 173 | $12,663 |
| Return visit (30+ min) | 172 | $7,155 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 171 | $2,229 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 242 | $1,416 |
| 2024 | 758 | 4 | 47 | $23,464 |
| 2023 | 1,005 | 6 | 51 | $25,912 |
| 2022 | 1,193 | 4 | 61 | $17,796 |
| 2021 | 813 | 5 | 72 | $9,992 |
| 2020 | 618 | 3 | 57 | $5,099 |
| 2019 | 255 | 2 | 54 | $1,705 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 179 | $12,237 |
| Return visit (30+ min) | 201 | $8,085 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 311 | $3,296 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 289 | $1,704 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 12 | $394 |
| New patient visit (45+ min) | 13 | $197 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 188 | $9,855 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 567 | $5,484 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 321 | $1,250 |
| Return visit (30+ min) | 117 | $1,207 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 504 | $4,552 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 48 | $2,945 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 192 | $1,185 |
| Return visit (30+ min) | 54 | $783 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 15 | $527 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 548 | $4,453 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 58 | $442 |
| Return visit (30+ min) | 12 | $204 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 234 | $1,578 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 21 | $126 |
Drugs they prescribed that Part D paid
$838,953
Pharmacies billed $838,953 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,083) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
2,455 generic and fewer than 11 brand-name prescriptions · $838,953 in drug cost · 14 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 348 | $464,778 | $1,336 |
| Xarelto | 109 | $125,790 | $1,154 |
| Entresto | 46 | $74,017 | $1,609 |
| Jardiance | 36 | $38,956 | $1,082 |
| Multaq | 17 | $35,504 | $2,088 |
See all 40 drugs
| Eliquis | 348 | $464,778 | $1,336 |
| Xarelto | 109 | $125,790 | $1,154 |
| Entresto | 46 | $74,017 | $1,609 |
| Jardiance | 36 | $38,956 | $1,082 |
| Multaq | 17 | $35,504 | $2,088 |
| Repatha Sureclick | 16 | $11,186 | $699 |
| Metoprolol | 358 | $5,693 | $16 |
| Atorvastatin | 365 | $3,718 | $10 |
| Amiodarone | 24 | $2,211 | $92 |
| Flecainide Acetate | 41 | $2,088 | $51 |
| Irbesartan | 114 | $2,003 | $18 |
| Clopidogrel | 178 | $1,929 | $11 |
| Rosuvastatin | 97 | $1,802 | $19 |
| Valsartan | 42 | $1,604 | $38 |
| Losartan | 131 | $1,328 | $10 |
| Diltiazem 24hr Er (Cd) | 36 | $1,275 | $35 |
| Bumetanide | 28 | $1,242 | $44 |
| Carvedilol | 148 | $1,241 | $8 |
| Amlodipine Besylate | 191 | $959 | $5 |
| Ezetimibe | 42 | $887 | $21 |
| Potassium Chloride | 32 | $853 | $27 |
| Digoxin | 11 | $678 | $62 |
| Furosemide | 107 | $622 | $6 |
| Lisinopril | 91 | $617 | $7 |
| Chlorthalidone | 40 | $612 | $15 |
| Olmesartan Medoxomil | 14 | $513 | $37 |
| Bisoprolol | 14 | $376 | $27 |
| Nifedipine Er | 12 | $359 | $30 |
| Hydralazine | 14 | $347 | $25 |
| Amlodipine Besylate-Benazepril | 32 | $215 | $7 |
| Metoprolol | 37 | $190 | $5 |
| Isosorbide Mononitrate Er | 15 | $181 | $12 |
| Pantoprazole | 15 | $156 | $10 |
| Nitroglycerin | 17 | $145 | $9 |
| Spironolactone | 45 | $145 | $3 |
| Simvastatin | 12 | $119 | $10 |
| Hydrochlorothiazide | 27 | $117 | $4 |
| Pravastatin | 15 | $85 | $6 |
| Warfarin | 13 | $82 | $6 |
| Amoxicillin | 12 | $28 | $2 |
Year by year
| 2024 | 3,083 | 469 | 0% (0) | None | $838,953 |
| 2023 | 2,855 | 447 | 0% (0) | None | $1,025,623 |
| 2022 | 2,794 | 440 | 0% (0) | 24% | $904,571 |
| 2021 | 2,394 | 382 | 0% (0) | 25% | $570,756 |
| 2020 | 1,422 | 270 | 0% (0) | 23% | $261,711 |
| 2019 | 410 | 105 | 0% (0) | 24% | $41,333 |
| 2018 | 198 | 51 | 0% (0) | 23% | $13,962 |
| 2017 | 61 | 28 | 0% (0) | 36% | $9,540 |
| 2016 | 93 | 24 | 0% (0) | 23% | $9,037 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Eliquis | 300 | $411,548 | $1,372 |
| Xarelto | 100 | $132,724 | $1,327 |
| Entresto | 60 | $94,894 | $1,582 |
| Jardiance | 24 | $33,062 | $1,378 |
| Multaq | 17 | $32,284 | $1,899 |
| Farxiga | 13 | $14,959 | $1,151 |
| Brilinta | 14 | $12,656 | $904 |
| Repatha Sureclick | 21 | $12,537 | $597 |
| Metoprolol | 273 | $6,865 | $25 |
| Atorvastatin | 364 | $6,467 | $18 |
| Irbesartan | 91 | $3,969 | $44 |
| Potassium Chloride | 58 | $3,530 | $61 |
| Flecainide Acetate | 39 | $3,282 | $84 |
| Amlodipine Besylate | 206 | $3,041 | $15 |
| Clopidogrel | 133 | $2,984 | $22 |
| Carvedilol | 160 | $2,978 | $19 |
| Losartan | 130 | $2,595 | $20 |
| Bumetanide | 34 | $2,436 | $72 |
| Rosuvastatin | 64 | $1,881 | $29 |
| Amiodarone | 26 | $1,798 | $69 |
| Furosemide | 147 | $1,562 | $11 |
| Valsartan | 29 | $1,468 | $51 |
| Ezetimibe | 34 | $1,409 | $41 |
| Lisinopril | 86 | $1,306 | $15 |
| Diltiazem 24hr Er (Cd) | 26 | $996 | $38 |
| Chlorthalidone | 26 | $705 | $27 |
| Isosorbide Mononitrate Er | 18 | $629 | $35 |
| Spironolactone | 45 | $617 | $14 |
| Hydralazine | 11 | $568 | $52 |
| Pantoprazole | 18 | $408 | $23 |
| Simvastatin | 19 | $327 | $17 |
| Warfarin | 12 | $296 | $25 |
| Metoprolol | 18 | $260 | $14 |
| Nitroglycerin | 19 | $246 | $13 |
| Hydrochlorothiazide | 40 | $233 | $6 |
| Pravastatin | 13 | $166 | $13 |
2022: 36 drugs
| Eliquis | 281 | $368,855 | $1,313 |
| Letairis | 11 | $130,796 | $11,891 |
| Xarelto | 85 | $113,571 | $1,336 |
| Entresto | 66 | $85,563 | $1,296 |
| Multaq | 33 | $44,281 | $1,342 |
| Jardiance | 15 | $13,203 | $880 |
| Repatha Sureclick | 13 | $7,177 | $552 |
| Pradaxa | 13 | $6,042 | $465 |
| Metoprolol | 305 | $5,971 | $20 |
| Irbesartan | 111 | $4,443 | $40 |
| Atorvastatin | 313 | $4,273 | $14 |
| Bumetanide | 38 | $4,103 | $108 |
| Clopidogrel | 170 | $3,249 | $19 |
| Carvedilol | 180 | $2,230 | $12 |
| Flecainide Acetate | 19 | $2,047 | $108 |
| Losartan | 93 | $1,930 | $21 |
| Amlodipine Besylate | 237 | $1,828 | $8 |
| Potassium Chloride | 52 | $1,767 | $34 |
| Valsartan | 33 | $1,368 | $41 |
| Diltiazem 24hr Er (Cd) | 20 | $1,257 | $63 |
| Ezetimibe | 17 | $1,194 | $70 |
| Furosemide | 138 | $1,112 | $8 |
| Amiodarone | 22 | $1,079 | $49 |
| Verapamil Er | 11 | $963 | $88 |
| Nifedipine Er | 11 | $873 | $79 |
| Lisinopril | 104 | $837 | $8 |
| Hydralazine | 25 | $614 | $25 |
| Chlorthalidone | 21 | $589 | $28 |
| Isosorbide Mononitrate Er | 20 | $543 | $27 |
| Rosuvastatin | 21 | $514 | $24 |
| Spironolactone | 42 | $461 | $11 |
| Nitroglycerin | 26 | $315 | $12 |
| Pantoprazole | 18 | $240 | $13 |
| Simvastatin | 14 | $194 | $14 |
| Metoprolol | 16 | $101 | $6 |
| Hydrochlorothiazide | 36 | $91 | $3 |
2021: 31 drugs
| Eliquis | 238 | $247,708 | $1,041 |
| Xarelto | 74 | $85,918 | $1,161 |
| Entresto | 55 | $50,516 | $918 |
| Brilinta | 31 | $29,312 | $946 |
| Multaq | 17 | $14,907 | $877 |
| Metoprolol | 292 | $7,498 | $26 |
| Irbesartan | 92 | $4,442 | $48 |
| Atorvastatin | 222 | $4,291 | $19 |
| Bumetanide | 39 | $4,023 | $103 |
| Potassium Chloride | 39 | $3,083 | $79 |
| Carvedilol | 168 | $2,458 | $15 |
| Amlodipine Besylate | 239 | $1,964 | $8 |
| Losartan | 84 | $1,803 | $21 |
| Rosuvastatin | 15 | $1,733 | $116 |
| Clopidogrel | 99 | $1,690 | $17 |
| Flecainide Acetate | 21 | $1,528 | $73 |
| Valsartan | 19 | $1,206 | $63 |
| Amiodarone | 33 | $1,115 | $34 |
| Chlorthalidone | 21 | $860 | $41 |
| Furosemide | 123 | $844 | $7 |
| Hydralazine | 24 | $827 | $34 |
| Bisoprolol | 11 | $753 | $68 |
| Diltiazem 24hr Er (Cd) | 17 | $646 | $38 |
| Lisinopril | 95 | $611 | $6 |
| Isosorbide Mononitrate Er | 22 | $476 | $22 |
| Nitroglycerin | 28 | $318 | $11 |
| Spironolactone | 17 | $190 | $11 |
| Metoprolol | 30 | $178 | $6 |
| Hydrochlorothiazide | 22 | $134 | $6 |
| Benazepril | 11 | $107 | $10 |
| Simvastatin | 11 | $84 | $8 |
2020: 24 drugs
| Eliquis | 150 | $139,598 | $931 |
| Xarelto | 39 | $46,212 | $1,185 |
| Brilinta | 25 | $19,865 | $795 |
| Metoprolol | 189 | $5,280 | $28 |
| Atorvastatin | 105 | $2,353 | $22 |
| Flecainide Acetate | 29 | $1,981 | $68 |
| Bumetanide | 18 | $1,823 | $101 |
| Carvedilol | 122 | $1,304 | $11 |
| Amlodipine Besylate | 132 | $1,174 | $9 |
| Losartan | 47 | $1,052 | $22 |
| Valsartan | 19 | $978 | $51 |
| Clopidogrel | 63 | $972 | $15 |
| Amiodarone | 18 | $746 | $41 |
| Hydralazine | 14 | $651 | $46 |
| Furosemide | 79 | $539 | $7 |
| Lisinopril | 98 | $531 | $5 |
| Nifedipine Er | 11 | $523 | $48 |
| Potassium Chloride | 15 | $489 | $33 |
| Diltiazem 24hr Er (Cd) | 16 | $416 | $26 |
| Nitroglycerin | 24 | $264 | $11 |
| Isosorbide Mononitrate Er | 13 | $261 | $20 |
| Spironolactone | 17 | $196 | $12 |
| Metoprolol | 20 | $136 | $7 |
| Hydrochlorothiazide | 11 | $90 | $8 |
2019: 10 drugs
| Brilinta | 41 | $17,513 | $427 |
| Eliquis | 22 | $7,767 | $353 |
| Metoprolol | 45 | $942 | $21 |
| Atorvastatin | 55 | $789 | $14 |
| Clopidogrel | 46 | $625 | $14 |
| Carvedilol | 33 | $364 | $11 |
| Furosemide | 21 | $130 | $6 |
| Amlodipine Besylate | 24 | $126 | $5 |
| Metoprolol | 16 | $110 | $7 |
| Lisinopril | 18 | $73 | $4 |
2018: 6 drugs
| Brilinta | 19 | $6,733 | $354 |
| Clopidogrel | 45 | $808 | $18 |
| Atorvastatin | 28 | $514 | $18 |
| Carvedilol | 13 | $84 | $6 |
| Furosemide | 17 | $44 | $3 |
| Lisinopril | 12 | $43 | $4 |
2017: 1 drug
| Clopidogrel | 18 | $322 | $18 |
2016: 2 drugs
| Eliquis | 16 | $6,551 | $409 |
| Metoprolol | 13 | $255 | $20 |
Money from drug and device companies
$118 in 2025
| 2025 | 4 | 5 | None | $118 |
| 2024 | 1 | 2 | None | $45 |
| 2022 | 2 | 2 | None | $210 |
| 2021 | 9 | 30 | None | $657 |
| 2020 | 11 | 32 | None | $677 |
| 2019 | 9 | 24 | None | $460 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Symplicity G3 | $38 | 2 payments
|
| Stryker | Flowtriever | $34 | 1 payment
|
| Teleflex | Guideliner | $29 | 1 payment
|
| Philips North America | Coronary Other | $17 | 1 payment
|
See all 5 published payments
| Medtronic | Meals · 2025-12-03 | Symplicity G3 | $24 |
| Medtronic | Meals · 2025-12-01 | Symplicity G3 | $14 |
| Philips North America | Meals · 2025-09-18 | Coronary Other | $17 |
| Teleflex | Meals · 2025-06-13 | Guideliner | $29 |
| Stryker | Meals · 2025-06-02 | Flowtriever | $34 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $45
| Philips North America | (6585) Omniwire | $45 | 2 payments
|
2022: $210
| Janssen Pharmaceuticals | Xarelto | $189 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $21 | 1 payment
|
2021: $657
| Actelion Pharmaceuticals US | Uptravi | $158 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $105 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $101 | 5 payments
|
| Chiesi USA | Kengreal | $67 | 5 payments
|
| Pfizer | Eliquis | $62 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $61 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $44 | 2 payments
|
| Amgen | Repatha | $33 | 2 payments
|
| Esperion Therapeutics | Nexletol | $27 | 1 payment
|
2020: $677
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $188 | 8 payments
|
| Amgen | Repatha | $165 | 7 payments
|
| Janssen Pharmaceuticals | Xarelto | $76 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $63 | 3 payments
|
| Amarin Pharma | Vascepa | $39 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $31 | 2 payments
|
| Pfizer | Eliquis | $30 | 1 payment
|
| Chiesi USA | Cleviprex 50mg/100ml | $28 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $22 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $18 | 1 payment
|
| iRhythm Technologies | Zio Patch | $18 | 1 payment
|
2019: $460
| Janssen Pharmaceuticals | Xarelto | $159 | 8 payments
|
| Amgen | Repatha | $63 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $59 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $50 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $47 | 3 payments
|
| Amarin Pharma | Vascepa | $22 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $22 | 1 payment
|
| Lundbeck | Northera | $22 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $16 | 1 payment
|
Professional record
- NPI
- 1972860104
- Licence
- CA 1073346
- Trained
- Geisel School of Medicine at Dartmouth, 2012
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2012-04-12
- NPI last updated
- 2023-03-07
- NPI record certified
- 2021-05-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1580 Valencia St Ste 802, San Francisco, CA, 94110 · 2351 Clay St, San Francisco, CA, 94115